Related by context. All words. (Click for frequent words.) 74 univariate 73 proportional hazards 72 multivariate analyzes 71 regression analysis 70 logistic regression 70 ANOVA 69 logistic regression models 68 nonparametric 67 Logistic regression 67 covariate 67 logistic regression analyzes 67 bivariate 67 Descriptive statistics 67 Univariate 67 logistic regression analysis 66 Multiple logistic regression 66 logistic regressions 66 chi squared 66 conditional logistic regression 65 covariates 65 logistic regression model 65 multivariate logistic regression 65 explanatory variables 65 multivariable logistic regression 65 Kaplan Meier survival 64 multivariate regression analysis 64 Kruskal Wallis test 64 meta analytic 64 Kaplan Meier curves 64 convergent validity 64 multivariate Cox 64 variance ANOVA 64 Linear regression 63 linear regression analysis 63 multiple linear regression 63 multivariate analysis 63 univariate analyzes 63 linear regressions 63 multivariable Cox 63 Kaplan Meier method 63 generalized estimating 63 Multivariate analysis 63 covariance 63 multiple logistic regression 63 Multivariable 63 prognostic factors 62 stepwise logistic regression 62 multivariable analysis 62 correlational 62 categorical variables 62 Bonferroni 62 pairwise comparisons 62 Poisson regression 62 Bonferroni correction 61 Kaplan Meier analysis 61 univariate analysis 61 correlation coefficients 61 meta regression 61 Pearson correlation coefficients 61 binary logistic regression 61 generalized linear 61 nomograms 61 intraclass correlation coefficients 61 Multiple linear regression 61 predictive validity 60 multivariate regression 60 confounding variables 60 regression equations 60 inferential statistics 60 odds ratios ORs 60 confidence intervals CIs 60 clinicopathological 60 allele frequencies 60 Multivariate logistic regression 60 Wilcoxon rank sum 60 multivariable 60 subgroup analyzes 59 Meta analyzes 59 interobserver reliability 59 bivariate analysis 59 Kruskal Wallis 59 linear regression analyzes 59 Child Behavior Checklist 59 interobserver 59 interrater reliability 59 Multivariate 59 bivariate analyzes 59 predictor variables 59 intraobserver 59 Subgroup analyzes 59 subscale scores 59 Univariate analysis 58 Mantel Haenszel 58 nomogram 58 tertiles 58 regressions 58 Interrater reliability 58 MDRD 58 subscales 58 electrophysiologic 58 potential confounders 58 Cronbach alpha 58 confounders 58 meta analyzes 58 prognostic variables 58 retest reliability 58 recursive partitioning 58 multivariate 58 Kaplan Meier curve 58 comorbidity 57 lognormal 57 Correlation coefficients 57 ANCOVA 57 Pearson correlation coefficient 57 Longitudinal studies 57 dichotomous variables 57 metabolic parameters 57 subtests 57 depressive symptom 57 androgen suppression 56 unpaired t 56 multivariable analyzes 56 Multivariable logistic regression 56 randomized controlled trials RCTs 56 Kaplan Meier 56 hierarchical clustering 56 Logistic regression analysis 56 gene polymorphisms 56 Observational studies 56 covariance ANCOVA 56 neuroimaging studies 56 Primary endpoints 56 Comorbidity 56 preoperative PSA 55 linear regression 55 logit 55 alexithymia 55 cystatin C 55 MMSE score 55 nonrandomized 55 prognostic significance 55 confounder 55 prespecified secondary 55 Regression analyzes 55 mRNA expression 55 comorbidities 55 APOE genotype 55 sociodemographic 55 demographic variables 55 longitudinal studies 55 psychometric properties 55 posttreatment 55 CORE OM 55 EQ 5D 55 RCTs 55 metaanalysis 55 QEEG 55 YMRS 55 HOMA IR 55 linear regression models 55 SGAs 55 etiologic 55 Subgroup analysis 55 sociodemographic variables 54 genotypic resistance 54 intima media thickness 54 mRS 54 residual confounding 54 coronary stenosis 54 carotid IMT 54 psychosocial variables 54 semiquantitative 54 mammographic density 54 unmeasured confounders 54 variables 54 affective disorders 54 differential gene expression 54 histopathologic 54 pharmacodynamic parameters 54 Pharmacokinetic parameters 54 familial aggregation 54 retrospective cohort 54 clinicopathological features 54 ECLS 54 Sensitivity analyzes 54 tHcy 54 genotype phenotype 54 psychiatric diagnoses 54 PSA kinetics 54 sociodemographic factors 54 syndromal 54 serum cotinine 54 platelet reactivity 54 APOC3 54 NIHSS 54 virologic responses 54 clinicopathologic 54 ROC curves 54 immunohistochemical staining 54 Reynolds Risk Score 54 BMI z 54 Likert 54 phylogenetic analyzes 54 prospective longitudinal 53 subclinical atherosclerosis 53 interrater 53 trials RCTs 53 HER2 expression 53 Wechsler Adult 53 stepwise regression 53 premorbid 53 MTT assay 53 posttest 53 DFT calculations 53 genetic polymorphisms 53 subscores 53 hsCRP 53 pairwise 53 exploratory endpoints 53 histological subtype 53 cerebral microbleeds 53 biochemical recurrence 53 neuroanatomical 53 serum PSA 53 allelic 53 F FDG PET 53 molecular subtypes 53 Randomized trials 53 clinico pathological 53 rs# [004] 53 regression coefficients 53 randomized controlled trials 53 Rating Scale BPRS 53 socioeconomic variables 53 null hypothesis 53 confounding factors 53 inter rater reliability 53 Cronbach 53 Main Outcome Measures 53 semistructured interview 53 RRs 53 prognostic indicators 53 Brief Psychiatric 53 MDRD equation 53 PSQI 53 fraternal twin pairs 53 neurophysiologic 53 epistasis 53 psychodynamic psychotherapy 53 hippocampal volume 53 HRQL 53 statistical analysis 53 Depression Inventory 53 chronicity 53 meta analysis 52 apolipoproteins 52 intact parathyroid hormone 52 multivariable regression 52 electroencephalographic 52 prospectively defined 52 multiplicative 52 et al SEE ARTICLE 52 immunohistochemical 52 DAS# scores 52 anthropometric measures 52 somatic symptoms 52 psychobiological 52 coinvestigators 52 symptom severity 52 dosimetric 52 d dimer 52 anthropometric measurements 52 TEAEs 52 symptomatic VTE 52 differentially expressed genes 52 dimensional echocardiography 52 FDG PET imaging 52 quantitative EEG 52 inbred strains 52 pharmacodynamic endpoints 52 immunostaining 52 Regression analysis 52 WOMAC pain 52 Secondary efficacy endpoints 52 microarray experiments 52 histopathological 52 statistical inference 52 somatoform disorders 52 Preoperatively 52 monozygotic 52 reliabilities 52 inflammatory biomarkers 52 IKDC 52 Symptom severity 52 chromatograms 52 psychiatric comorbidity 52 cognitive affective 52 histone modifications 52 susceptibility loci 52 methodologic 52 VKORC1 52 perfusion abnormalities 52 transient elastography 52 MR spectroscopy 52 immunohistochemical analysis 52 pharmacokinetic parameters 52 SerDes transceivers 52 plasma pharmacokinetics 52 subanalysis 52 metabolite concentrations 52 epidemiologic studies 52 amino acid substitutions 52 eigenvalue 52 quadratic 52 quartiles 52 gravitational redshift 52 neuropsychological assessment 52 euthymic patients 52 quantile 52 factorial 52 glomerular filtration rate 52 χ 52 histologic subtypes 52 Doppler sonography 52 multivariable adjusted 51 subscore 51 statistically significant correlation 51 genotypic 51 sensitivity specificity 51 polynomials 51 surrogate endpoint 51 psychotherapies 51 invariants 51 intraclass correlation coefficient 51 cytologic 51 endometrial carcinoma 51 prespecified 51 statistically significant differences 51 poststroke 51 laboratory abnormalities 51 plasma homocysteine 51 discriminant analysis 51 morphometric 51 RT PCR assay 51 estimated GFR 51 NHANES III 51 preoperatively 51 predictors 51 prostate cancer CaP 51 monozygotic twins 51 unmeasured confounding 51 periprocedural MI 51 physiologic parameters 51 Bayesian 51 psychopathological symptoms 51 siRNA knockdown 51 Oncotype DX Recurrence Score 51 serum retinol 51 Baseline characteristics 51 prognostic biomarker 51 Histopathological 51 composite endpoint 51 Histologic 51 pressor response 51 autocorrelation 51 post hoc 51 oncologic outcomes 51 virological response 51 callous unemotional traits 51 PCWP 51 tumor histology 51 Multivariate analyzes 51 histopathologic findings 51 laterality 51 Index CDAI 51 cognitive domains 51 postoperative chemotherapy 51 CT urography 51 randomized trials 51 Monte Carlo simulations 51 Scale Cognitive Subscale 51 Gaussian distribution 51 discriminant validity 51 comorbid disorders 51 prostate cancer PCa 51 Likert type 51 DLTs 51 neuropathological 51 Likert scale 51 adenotonsillectomy 51 correlations 51 serum calcium 51 Depressive symptoms 51 MMSE 51 causal inference 51 causal pathways 51 Cytogenetic 51 Y BOCS 51 Predictors 51 plasma cortisol 51 STEP BD 51 psychiatric comorbidities 51 potentially confounding variables 51 ADAS cog 51 behavioral disinhibition 51 neuropathologic 51 internalizing behaviors 51 genomewide 51 genetic relatedness 51 paralogs 51 sociodemographic characteristics 51 binomial model 51 SLN biopsy 51 intima media thickness IMT 51 HAM D# 51 State Examination MMSE 51 colorectal adenoma 51 DCE MRI 51 airway responsiveness 51 genetic loci 50 HIV tropism 50 observational studies 50 spirometric 50 Montgomery Åsberg Depression 50 Ki# 50 comorbid depression 50 Pain Rating Scale 50 QTc prolongation 50 #F FDG PET 50 lipid abnormalities 50 RRM1 50 histopathologic diagnosis 50 MMSE scores 50 Charlson Comorbidity Index 50 estrogen receptor ER 50 methodological approaches 50 variograms 50 fluoxetine Prozac 50 K ras mutations 50 timepoints 50 eigenvalues 50 physiologic responses 50 Cockcroft Gault 50 DSM IV diagnoses 50 antiplatelet drugs 50 albumin creatinine ratio 50 functional neuroimaging 50 plain radiographs 50 depressive symptomatology 50 FDG PET 50 hematopoietic cancers 50 nucleotide substitutions 50 κ 50 parameter estimation 50 induced sputum 50 nonpharmacologic 50 AST ALT 50 psychiatric morbidity 50 dichotomized 50 econometric analyzes 50 Logistic regression analyzes 50 SCr 50 serum cortisol 50 nodal metastases 50 assortative mating 50 Pain Intensity 50 MetS 50 patient subpopulations 50 transcranial Doppler 50 periprocedural 50 neurocognitive function 50 potential confounding variables 50 #q# deletion syndrome 50 indels 50 Cognitive impairment 50 secondary efficacy endpoints 50 rCBF 50 cortical activation 50 x ray crystallographic 50 thyroglobulin 50 neuropsychological tests 50 contralateral breast cancer 50 lymphovascular invasion 50 lymphadenectomy 50 Recurrence Score 50 generalizability 50 prospectively randomized 50 linkage disequilibrium 50 morphometric vertebral fractures 50 troponins 50 methacholine challenge 50 P = .# 50 conventional angiography 50 hormone receptor status 50 Framingham Risk Score 50 radiographic findings 50 Heritability 50 tDCS 50 HAQ DI 50 epidemiological studies 50 Finite element 50 nonfatal MI 50 System IPSS 50 extrapyramidal symptoms 50 genetic aberrations 50 male Wistar rats 50 antioxidant supplementation 50 Framingham Offspring 50 microsatellite instability 50 TIMP 1 50 UKPDS 50 missense mutations 50 affective psychosis 50 leukocyte counts 50 FEV ^ sub 50 serum concentrations 50 methodological differences 50 exhaled nitric oxide 50 SpHb monitoring 50 Mendelian randomization 50 receptor subtypes 50 generalisability 50 sonographically guided 50 serum estradiol 50 APACHE II 50 invariance 50 grade interpolation 50 COMT genotype 50 Epworth Sleepiness Scale 50 PON1 50 IL#B 50 FDG-PET/CT 50 Secondary endpoints 50 Cardiorespiratory fitness 50 cTnT levels 50 Mechanistic studies 50 cystatin 50 QTc 50 fig. S4 50 ABCB1 50 Morphological 50 pharmacologic treatments 50 ADAS Cog 50 probands 50 gonadal hormones 50 Supplementary Table 50 RECIST Response Evaluation Criteria 50 biopsy Gleason 50 transcranial Doppler ultrasound 50 EuroSCORE 50 HAMD 50 CYP#D# inhibitor 50 observational cohort 50 Monte Carlo Simulation 50 imply causality 50 statistically nonsignificant 49 methodological flaws 49 PSADT 49 TOP2A 49 histologic subtype 49 clinically meaningful differences 49 comorbid conditions 49 dosage regimens 49 Histological 49 #OHD 49 dopamine receptor gene 49 prospective observational studies 49 neurocognitive impairment 49 NIHSS score 49 liver biopsies 49 lymph node metastasis 49 Histopathologic 49 IVIVC 49 depressive symptoms 49 dyssynchrony 49 developmental trajectories 49 neoadjuvant chemotherapy 49 spectroscopic techniques 49 chemoradiotherapy 49 enzyme immunoassay EIA 49 Quantitative RT PCR 49 transcriptional profiling 49 NHAMCS 49 MSLT 49 extensive metabolizers 49 subtest 49 Immunohistochemistry 49 MLH1 49 cytogenetic abnormalities 49 dose Iluvien 49 empiric 49 breast cancer subtypes 49 familial clustering 49 Main Outcome Measure 49 dysthymia 49 GABRA2 49 SNP rs# [002] 49 discriminant 49 prospective multicentre 49 ABL1 49 CYP#D# genotype 49 primary aldosteronism 49 inhibin B 49 longitudinal cohort study 49 echocardiographic 49 PERMP 49 hip resurfacing arthroplasty 49 Intervention Trial 49 multivariate adjustment 49 adjuvant therapies 49 treatment emergent AEs 49 surrogate markers 49 Phylogenetic analyzes 49 Genotypic 49 psychophysiological 49 adjuvant systemic 49 regression coefficient 49 Visual Analogue Scale VAS 49 CT perfusion 49 kidney allograft 49 doxorubicin docetaxel 49 Scale PANSS 49 CALGB 49 variate 49 urodynamic parameters 49 stone formers 49 ARB telmisartan 49 colorectal carcinogenesis 49 perfusion CT 49 irbesartan 49 histologic 49 rheumatoid factor 49 D dimer 49 dose proportionality 49 point Likert scale 49 endometrial thickness 49 TP# mutations 49 β blockers 49 prospective cohort 49 Hidden Markov 49 Randomized clinical trials 49 pleiotropy 49 cranial irradiation 49 coronary calcification 49 chemoprevention trials 49 psychodynamic therapy 49 miRNA expression 49 Efficacy endpoints 49 nonvertebral fractures 49 Bayesian analysis 49 regression 49 urodynamic studies 49 postintervention 49 coefficients 49 dopamine transporter gene 49 intraventricular 49 Discounted Cash Flow 49 chest radiographs 49 PANSS 49 Rating Scale MADRS 49 statistically significant correlations 49 tertile 49 adenoma recurrence 49 sonographic findings 49 vitro experiments 49 coronary CTA 49 interpersonal psychotherapy 49 p = .# [002] 49 ConclusionThis 49 SLC#A# [002] 49 etiologic factors 49 Doppler echocardiography 49 silent myocardial ischemia 49 nonoperative treatment 49 hypericin 49 perinatal outcomes 49 FDG PET scans 49 symptomatology 49 serum PTH 49 MADRS 49 acetabular fracture 49 Alzheimer Disease Assessment 49 lipid lowering drugs 49 Correlations 49 Fibromyalgia Impact Questionnaire 49 Health Assessment Questionnaire 49 femoral neck BMD 49 heterozygotes 49 schizotypal traits 49 stochastic simulation 49 actigraphy 49 serum markers 49 pCR 49 darunavir ritonavir 49 wavelet transform 49 pharmacodynamic markers 49 obstructive coronary artery 49 baseline HbA1c 49 SAXS 49 Rating Scale UPDRS 49 TNM staging 49 placebo controlled studies 49 IntroductionThe 49 radiographic progression 49 proton MR spectroscopy 49 specific antigen PSA 49 interobserver agreement 49 Glomerular filtration rate 49 aortic calcification 49 Unified Parkinson Disease 49 TIMI 49 viral kinetics 49 myocardial viability 49 MGUS 49 endophenotypes 49 angiotensin converting enzyme inhibitors 49 #S rRNA gene 49 perturbation theory 49 BI RADS 49 hyperintense lesions 49 body fatness 49 Kaplan Meier estimates 49 Socioeconomic status 49 achieved statistical significance 49 RE LY ® 49 thickness IMT 49 Mechanistic 49 PCa 49 microsimulation model 49 androgen deprivation 49 parous 49 optimization algorithms 49 hsCRP levels 49 NAMCS 49 thermodynamic modeling 49 multivariate statistical 49 kurtosis 49 preoperative diagnosis 48 microalbumin 48 transgene expression 48 Charlson comorbidity index 48 symptomatic intracerebral hemorrhage 48 pathophysiological mechanisms 48 haplotypes 48 carotid intima media 48 mechanistic studies 48 nongenetic 48 econometric 48 Mutational 48 SYNTAX 48 interindividual variability 48 Distress Scale 48 karyotypes 48 dimensional sonography 48 Kids Inpatient Database 48 DSM IV SCID 48 Lp PLA 2 48 nulliparous women 48 methylation patterns 48 Haplotype 48 Negative Syndrome 48 liver histology 48 pharmacological interventions 48 RECIST criteria 48 PSA nadir 48 Csernansky 48 LDL HDL 48 noncardiac 48 Edinburgh Postnatal Depression 48 anthropometry 48 VNTR 48 albumin excretion rate 48 intracellular signaling 48 p = #.# [003] 48 VADT 48 NSABP B 48 dinucleotide 48 ultrasonographic 48 phylogenies 48 bone scintigraphy 48 nonrandomized studies 48 Statistical analyzes 48 HOXB# 48 HbA 1c 48 Neuropsychiatric Inventory NPI 48 N glycan 48 Bayesian probability 48 symptomatic pulmonary embolism 48 Bayesian statistics 48 postoperative mortality 48 QTc intervals 48 prospective observational cohort 48 transrectal ultrasound guided 48 mechanistic insights 48 genes CYP#C# 48 amygdala reactivity 48 microdose 48 Intermountain Risk Score 48 dimensional ultrasonography 48 subthreshold 48 urine cytology 48 HDRS 48 histopathologic examination 48 gene expression profiles 48 mRNA molecules 48 immunological responses 48 Inventory BPI 48 gene loci 48 serum vitamin D 48 enzyme kinetics 48 measurements 48 postmenopausal hormone 48 PCI ExTRACT TIMI 48 Cardiopulmonary bypass 48 serum triglyceride 48 preoperative chemotherapy 48 lymphocyte count 48 dyads 48 noninferiority 48 sensory modalities 48 Doppler ultrasonography 48 plasma lipid 48 Mini Mental 48 chromosomal aberrations 48 Suicidal ideation 48 carotid artery thickness 48 McGill Pain Questionnaire 48 selenium supplementation 48 allostatic load 48 glucose abnormalities 48 polygenic 48 Monte Carlo simulation 48 polysomnogram 48 FDG PET scan 48 Bayesian inference 48 subcellular localization 48 transrectal ultrasonography 48 Global Impression CGI 48 proband 48 finite element method 48 prognostically 48 plasma folate 48 serum cotinine levels 48 neuropsychological assessments 48 neurosensory 48 locoregional recurrence 48 liver transplant recipients 48 microarray gene expression 48 neurodevelopmental outcome 48 Montgomery Asberg Depression 48 ALLHAT 48 Bayes theorem 48 CVD mortality 48 EEG recordings 48 Negative Symptoms 48 HRCT 48 neoadjuvant 48 mycophenolate mofetil 48 lipid lowering agents 48 unmeasured factors 48 preoperative 48 polyarticular 48 corrected QT interval 48 thermodynamic stability 48 transthoracic echocardiography 48 NYHA functional class 48 RNFL thickness 48 Wechsler Memory 48 unipolar depression 48 ELBW infants 48 randomisation 48 concomitant medications 48 studys 48 biventricular repair 48 QRISK 48 NLSY 48 microvessel density 48 NNRTI resistance 48 urodynamic 48 cilostazol 48 % Confidence Interval 48 PITX2 methylation 48 neuromotor 48 haematologic 48 NIH CPSI 48 macrovascular disease 48 ADCS CGIC 48 #S rRNA 48 Early Childhood Longitudinal Study 48 monozygotic twin 48 FOLPI 48 dose dependently 48 statistical analyzes 48 CARDIA 48 pure fructose 48 CTEPH 48 retrospective cohort study 48 trigonometric functions 48 neurophysiological 48 aldosterone antagonist 48 artifactual 48 EUS FNA 48 carotid plaque 48 physicochemical properties 48 thromboembolic complications 48 serum leptin 48 fasting insulin 48 baseline LDH 48 genomic alterations 48 PIB PET 48 subtypes 48 numerical simulations 48 recurrent venous thromboembolism 48 diastolic pressures 48 estimated glomerular filtration 48 coronary stenoses 48 Personality traits 48 pharmacokinetics PK 48 prognostic factor 48 synaptic proteins 48 histologically proven 48 hemodynamic variables 48 genomewide association studies 48 QIDS SR 48 HCV SPRINT 48 acetabular fractures 48 baroreceptor 48 Tumor Response 48 airway hyperresponsiveness 48 immunoblotting 48 androgen depletion 48 TNSS 48 BEXXAR Therapeutic Regimen 48 semistructured interviews 48 variography 48 extraversion 48 Cognitive Abilities Test 48 tipranavir ritonavir 48 Visual Analog 48 plasma adiponectin 48 attain statistical significance 48 WAIS III 48 PESQ 48 homocysteine concentrations 48 gene APOE 48 Probabilistic 48 nonsignificant 48 antiangiogenic agents 48 BPRS 48 radiographic outcomes 48 hyperintensities 48 visceral adiposity 48 electrophysiological 48 inotropic agents 48 TT genotype 48 placebo controlled trials 48 radiochemotherapy 48 K#N 48 Raven Progressive Matrices 48 diffusion tensor 48 subtrochanteric 48 scintigraphy 48 HADS 48 Theoretical calculations 48 subclasses 48 methotrexate monotherapy 48 etiologies 48 varicoceles 48 cDNA libraries 48 hemostatic efficacy 47 CIN2 + 47 biochemical abnormalities 47 elevated CRP 47 ECG gated 47 statistically significant 47 immunoreactivity 47 prostatic adenocarcinoma 47 BCL#A 47 mosaicism 47 concordance 47 response pCR 47 CHD mortality 47 atherothrombotic disease 47 prognostic indicator 47 Regression 47 AVERROES 47 transaminase elevations 47 affective psychoses 47 binocular rivalry 47 hemorrhagic complications 47 lymph node involvement 47 CaPSURE 47 dichotomous variable 47 Multivariate analysis revealed 47 germline mutations 47 substudy 47 phylogenetic analysis 47 phenotypes 47 autonomic dysfunction